About Societal CDMO
Societal CDMO is a Healthcare company based in San Diego (United States) founded in 1982, and was acquired by CoreRx in February 2024. Provider of clinical trial, formulation development, packaging, and quality assurance services. Its focus areas include Biopharma Outsourcing and Diversified. Its legal entity is SOCIETAL CDMO, INC. Its competitors include ANI Pharmaceuticals, Red Nucleus and Aptar.
Company details
Societal CDMO was founded in 1982 and is based in San Diego, United States. Operations focus on the pharmaceutical sector as a contract development and manufacturing organization. Services encompass clinical trial support, formulation development, packaging solutions, and quality assurance processes. These offerings assist clients in drug product lifecycle management from development through commercialization.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Website societalcdmo.com
- Acquired by CoreRx (Feb 2024)
- Legal Name Societal Cdmo, Inc.
Funding Insights of Societal CDMO
- Total Rounds 2
- Last Round Debt – Conventional — $125M
- First Round $16M
(Jul 2015)
- Investors Count 2
All 2 funding rounds of Societal CDMO with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2017 | $125M | Debt – Conventional | – | – | |
| Jul 2015 | $16M | Post-IPO | – | – |
3 investors in total: 3 institutional.
Investors in Societal CDMO
Societal CDMO has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include CoreRx, Athyrium Capital Management and Broadfin Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global private equity investments are managed by the firm. | athyrium.com | New York, United States | ||
Investment opportunities in healthcare are managed by Broadfin Capital. | 2005 | broadfin.com | Melville, United States | |
CDMO with a focus on early phase drug product development | 2006 | corerxpharma.com | Clearwater, United States |
Investor details for Societal CDMO
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Societal CDMO
17 people are tracked at Societal CDMO (9 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Nikki Lezama | Head Of TA And L&d | Leadership |
Julie Christian | Associate Director, Facilities And Engineering | Leadership |
J. David Enloe, Jr. | President and Chief Executive Officer | Leadership |
Scott Rizzo | Chief Operating Officer | Leadership |
Shazib Jamil | Vice President Supply Chain | Leadership |
Danielle Grosso | Director Project Management | Leadership |
Carol Bolger | Director, IT Applications | Leadership |
Megha Nair | Associate Director, Engineering | Leadership |
Tim Roach | Senior Director, Plant Engineering | Leadership |
Gerardo Valiente | Facilities Engineer III | Team |
John Facemire | Process Engineer IV | Team |
Juan Dodaro | Manager, IT Infrastructure & Operations | Team |
Clinton Ballard | Validation Engineer III | Team |
Darren Allen Jr. | Validation Engineer III | Team |
Jeremy Barrett | Senior Maintenance Engineer | Team |
Anvesh Vemulapalli | Senior Validation Engineer | Team |
Anne Marie Shapiro | Business Support Specialist | Team |
Complete people profiles for Societal CDMO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Societal CDMO
5 dated milestones of Societal CDMO across 42 years, from founding to its latest funding, stage changes and deals.
- Founded Societal CDMO is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $16.0M.
- Funding Latest funding round, Debt – Conventional, of $125.0M.
- Exit Acquired by CoreRx.
Competitors of Societal CDMO
Societal CDMO has 3 listed competitors in our database. They include ANI Pharmaceuticals, Red Nucleus and Aptar.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| anipharmaceuticals.com | 1996 | Baudette, United States | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | ||
| rednucleus.com | 2014 | Yardley, United States | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | ||
| aptar.com | 1992 | Crystal Lake, United States | 232 | Regulatory support, brand differentiation, and prototyping services are provided. |
Detailed competitors of Societal CDMO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Societal CDMO (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Societal Cdmo
Complete news archive for Societal CDMO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Societal CDMO
Societal CDMO was founded in 1982 and raised its 1st funding round 33 years after it was founded.
Societal CDMO is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Annual revenue of Societal CDMO is $94.64M as on Dec 31, 2023.
Societal CDMO was founded in 1982 and is based in San Diego, United States. Operations focus on the pharmaceutical sector as a contract development and manufacturing organization. Services encompass clinical trial support, formulation development, packaging solutions, and quality assurance processes. These offerings assist clients in drug product lifecycle management from development through commercialization.
Societal CDMO's top competitors include ANI Pharmaceuticals, Aptar and Red Nucleus.
Societal CDMO has 3 investors. Key investors include CoreRx, Athyrium Capital Management, and Broadfin Capital.
Societal CDMO operates through Societal Cdmo, Inc..
Yes. Societal CDMO was acquired by CoreRx in February 2024.